These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Prospective evaluation of the effectiveness of high doses of methylprednisolone in multiple sclerosis]. Wajgt A; Szczechowski L; Marczewska E; Grechuta M; Strzyzewska L; Gadomska B; Szyrocka-Szwed K Neurol Neurochir Pol; 1988; 22(3):188-94. PubMed ID: 3065667 [TBL] [Abstract][Full Text] [Related]
49. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis. Durelli L; Baggio GF; Bergamasco B; Barile C; Cocito D; Delsedime M; Perla F; Riccio A; Bergamini L Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340 [No Abstract] [Full Text] [Related]
50. [Prospective assessment of combined treatment with high doses of intravenous methylprednisolone and long term administration of Isoprinosine in multiple sclerosis patients]. Maciejek Z; Niezgodzińska-Maciejek A Neurol Neurochir Pol; 1993; 27(3):321-9. PubMed ID: 7694166 [TBL] [Abstract][Full Text] [Related]
51. Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial. Barnes MP; Bates D; Cartlidge NE; French JM; Shaw DA J Neurol Neurosurg Psychiatry; 1987 Nov; 50(11):1402-6. PubMed ID: 3320274 [TBL] [Abstract][Full Text] [Related]
52. A double-blind placebo-controlled trial of methylprednisolone pulse therapy in active rheumatoid disease. Williams IA; Baylis EM; Shipley ME Lancet; 1982 Jul; 2(8292):237-40. PubMed ID: 6124671 [TBL] [Abstract][Full Text] [Related]
53. A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. van de Wyngaert FA; Beguin C; D'Hooghe MB; Dooms G; Lissoir F; Carton H; Sindic CJ Acta Neurol Belg; 2001 Dec; 101(4):210-6. PubMed ID: 11851027 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of oral prednisolone tapering following intravenous methyl prednisolone in patients with multiple sclerosis relapses: A randomized, double-blind, placebo-controlled trial. Bazi A; Baghbanian SM; Ghazaeian M; Saeedi M; Hendoiee N Mult Scler Relat Disord; 2021 Jan; 47():102640. PubMed ID: 33310419 [TBL] [Abstract][Full Text] [Related]
55. A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment. Edwards JC; Snaith ML; Isenberg DA Ann Rheum Dis; 1987 Oct; 46(10):773-6. PubMed ID: 3318723 [TBL] [Abstract][Full Text] [Related]
56. IV immunoglobulins as add-on treatment to methylprednisolone for acute relapses in MS. Sorensen PS; Haas J; Sellebjerg F; Olsson T; Ravnborg M; Neurology; 2004 Dec; 63(11):2028-33. PubMed ID: 15596745 [TBL] [Abstract][Full Text] [Related]
57. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540 [TBL] [Abstract][Full Text] [Related]
58. High-dose intravenous corticosteroids in the treatment of multiple sclerosis. Ohno R; Hamaguchi K; Sowa K; Tanaka H; Watanabe Y Jpn J Med; 1987 May; 26(2):212-6. PubMed ID: 3626160 [TBL] [Abstract][Full Text] [Related]
59. Monthly methylprednisolone in combination with interferon beta or glatiramer acetate for relapsing-remitting multiple sclerosis: A multicentre, single-blind, prospective trial. Ozakbas S; Cinar BP; Kosehasanoğullari G; Kahraman T; Oz D; Kursun BB Clin Neurol Neurosurg; 2017 Sep; 160():69-72. PubMed ID: 28689102 [TBL] [Abstract][Full Text] [Related]
60. Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. Reliability, validity and sensitivity to disease progression. Multiple Sclerosis Study Group. Syndulko K; Ke D; Ellison GW; Baumhefner RW; Myers LW; Tourtellotte WW Mult Scler; 1996 Oct; 2(3):142-56. PubMed ID: 9345379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]